Indiplon: a single compound in two formulations for the treatment of insomnia
2006
Indiplon is a nonbenzodiazepine hypnotic being developed for the treatment of insomnia by Neurocrine Biosciences Inc. It is an allosteric modulator of the γ-amino butyric acid-α receptor complex with very high affinity for the α1 subunit, which is associated with hypnotic activity, sedation and amnesia. Indiplon has been developed in two different formulations: an immediate-release version targeting sleep initiation insomnia and a modified-release version addressing sleep maintenance insomnia. Early results from clinical trials indicate that both formulations are well tolerated and effective at improving objective and subjective measures of sleep.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
71
References
0
Citations
NaN
KQI